Innervate Radiopharmaceuticals Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Investors
-
2
Innervate Radiopharmaceuticals General Information
Description
Developer of positron emission tomography (PET) imaging and therapeutic radiopharmaceuticals intended to improve image resolution. The company offers an imaging biomarker that has significant advantages over single photon emission computed tomography (SPECT), the current standard of care for biomarker imaging in neuroblastoma patients, enabling the healthcare industry to improve reliability and accuracy in the detection of disease, in turn, leading to important improvements in patient management and outcomes for patients with neuroblastoma and potentially other diseases.
Contact Information
Website
www.innervaterp.comCorporate Office
- 175 Elm Road
- Englewood, NJ 07631
- United States
Corporate Office
- 175 Elm Road
- Englewood, NJ 07631
- United States
Innervate Radiopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 05-Mar-2026 | In Progress | Generating Revenue | |||
| 3. Later Stage VC | 20-Mar-2025 | Completed | Clinical Trials - Phase 3 | |||
| 2. Seed Round | 14-Jan-2022 | $250K | Completed | Stealth | ||
| 1. Angel (individual) | 04-Jun-2019 | $250K | $250K | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Innervate Radiopharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mountain State Capital | Venture Capital | Minority | ||
| Robin Hood Ventures | Angel Group | Minority |
Innervate Radiopharmaceuticals FAQs
-
When was Innervate Radiopharmaceuticals founded?
Innervate Radiopharmaceuticals was founded in 2019.
-
Where is Innervate Radiopharmaceuticals headquartered?
Innervate Radiopharmaceuticals is headquartered in Englewood, NJ.
-
What industry is Innervate Radiopharmaceuticals in?
Innervate Radiopharmaceuticals’s primary industry is Drug Discovery.
-
Is Innervate Radiopharmaceuticals a private or public company?
Innervate Radiopharmaceuticals is a Private company.
-
What is Innervate Radiopharmaceuticals’s current revenue?
The current revenue for Innervate Radiopharmaceuticals is .
-
How much funding has Innervate Radiopharmaceuticals raised over time?
Innervate Radiopharmaceuticals has raised $250K.
-
Who are Innervate Radiopharmaceuticals’s investors?
Mountain State Capital and Robin Hood Ventures have invested in Innervate Radiopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process